Haematology 2018

Cumulative incidence of breast cancer among female HL survivors by RT field, prescribed dose and duration of intact ovarian function 174 BC cases and 466 controls nested in cohort of 3905 5-yr HL survivors treated 1965-2000 Conclusion: • Hormone replacement therapy does not appear to increase BC risk for HL survivors with therapy-induced early menopause.

Krul et al, IJROBP 2017